Current therapeutic possibilities in primary and secondary amyloidosis and our experience with 31 patients
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F03%3A00009215" target="_blank" >RIV/00216208:11110/03:00009215 - isvavai.cz</a>
Alternative codes found
RIV/00064165:_____/03:00001062
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Current therapeutic possibilities in primary and secondary amyloidosis and our experience with 31 patients
Original language description
AA amyloidosis, AL amyloidosis, amyloid, ASCT, DMARDs, immunotheraphy
Czech name
Současné léčebné možnosti u primární a sekundární amyloidózy a naše zkušenosti s 31 pacienty
Czech description
AA amyloidóza, AL amyloidóza, amyloid, autologní transplantace kmenových buněk, imunoterapie
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
EB - Genetics and molecular biology
OECD FORD branch
—
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2003
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Nephrology, Dialysis, Transplantation
ISSN
0931-0509
e-ISSN
—
Volume of the periodical
18
Issue of the periodical within the volume
Suppl. 5
Country of publishing house
GB - UNITED KINGDOM
Number of pages
3
Pages from-to
38-40
UT code for WoS article
—
EID of the result in the Scopus database
—